MAXY - Maxygen, Inc. Archives

[Member] MAXY Offers a Rare Low Risk Investment Opportunity

Maxygen (MAXY) historically has been a biotech company engaged in discovery and development of protein pharmaceuticals for the treatment of chemotherapy-induced neutropenia and acute radiation syndrome. For the last several years, the company has stopped its operations completely and is actively trying to monetize its R&D assets and return value to the shareholders. As of… [Read More]